RecruitingNCT07446608

MRI-Based Prediction of Dienogest Response in Endometriosis

Predicting the Efficacy of Dienogest in Patients With Endometriosis Using MRI


Sponsor

Chungnam National University Sejong Hospital

Enrollment

48 participants

Start Date

Oct 14, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this prospective observational study is to learn whether magnetic resonance imaging (MRI) findings can help predict treatment response to dienogest in women with endometriosis. Endometriosis is a common gynecologic condition that can cause chronic pelvic pain and negatively affect quality of life. Although dienogest is widely used as a standard medical treatment, individual responses to treatment vary. The main questions this study aims to answer are: * Whether baseline MRI characteristics of endometriotic lesions are associated with improvement in pelvic pain after dienogest treatment. * Whether MRI findings can help identify patients who are more likely to benefit from dienogest therapy. Participants diagnosed with endometriosis who are prescribed dienogest as part of their routine clinical care will be enrolled. This study does not assign any investigational intervention. Participants will undergo standard clinical follow-up, including pelvic pain assessment using visual analog scale (VAS) scores, quality of life questionnaires, and routine MRI examinations. Clinical and imaging data will be collected prospectively and analyzed to explore imaging predictors of treatment response.


Eligibility

Sex: FEMALEMin Age: 19 YearsMax Age: 45 Years

Inclusion Criteria4

  • Female participants who have received a full explanation of the study and have provided written informed consent
  • Women aged 19 to 45 years who have been diagnosed with endometriosis by a board-certified obstetrician-gynecologist
  • Patients who have not received any hormonal treatment within the previous 3 months
  • Patients who have never been treated with dienogest

Exclusion Criteria5

  • Patients with a history of treatment with dienogest
  • Patients with contraindications to dienogest
  • Patients who are unable to undergo magnetic resonance imaging (MRI) (e.g., presence of metallic implants)
  • Patients who are currently pregnant or planning pregnancy within the next 6 months
  • Patients with poor general medical condition, as judged by the investigator

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Sejong Chungnam National University Hospital

Sejong, Sejong Special Self-Governing City, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07446608